2020 Patient Advocacy Prescription Drug Pricing 
Health Populi
OCTOBER 8, 2019
Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027.
Health Populi
JANUARY 29, 2019
See the dark blue dot in 2023 north of the other dots, representing the median costs for a non-oncology drug with orphan status priced around $300,000. Other key trends to expect leading to 2023 will be: The rise of patient advocacy roles in pharma companies. Thus far, the FDA has been welcoming to these concepts.
Expert insights. Personalized for you.
108 
Let's personalize your content